https://www.selleckchem.com/pr....oducts/gsk2126458.ht
AL2106 is a new medical device based on a mixture of chondroitin sulphate in a xyloglucan and glycerol solution made to maximize its bioadhesive capability to the esophageal mucosa. The aim of the present study was twofold to evaluate the AL2106 protective effect on the esophageal mucosa when exposed to an acidic solution mimicking gastric reflux and to assess the resilience of this effect to saline washing. A porcine ex vivo model was used and the effects of the new medical device were compared to a sodium alginate suspension (SAS)